Elena Croce
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Polyomavirus and related diseases
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 3
- Cutaneous Melanoma Detection and Management 2
-
- Immunotherapy and Immune Responses 4
- Co-authors
- Francesco Spagnolo (14 shared papers)Enrica T. Tanda (14 shared papers)Andrea Boutros (12 shared papers)Luca Arecco (8 shared papers)Paola Queirolo (5 shared papers)Matteo Lambertini (6 shared papers)Marco Ferrari (1 shared paper)P. Pronzato (5 shared papers)
- Journals
- Frontiers in Oncology (3 papers)European Journal of Cancer (2 papers)European Journal of Clinical Investigation (1 paper)Journal of Geriatric Oncology (1 paper)Critical Reviews in Oncology/Hematology (1 paper)
- Partner nations
- Italy
In The Last Decade
Elena Croce
14 papers receiving 242 citations
Elena Croce's Hit Papers
Peers
Comparison fields: 5 of 53
- Oncology 128
- Immunology 51
- Ophthalmology 20
- Dermatology 10
- Epidemiology 27
Countries citing papers authored by Elena Croce
This map shows the geographic impact of Elena Croce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Croce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Croce more than expected).
Fields of papers citing papers by Elena Croce
This network shows the impact of papers produced by Elena Croce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Croce. The network helps show where Elena Croce may publish in the future.
Co-authors
The 25 scholars most cited alongside Elena Croce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The treatment of advanced melanoma: Current approaches and new challenges Hit paper breakdown → | 2024 | 67 |
| 2 | 2021 | 29 | |
| 3 | 2021 | 27 | |
| 4 | 2023 | 26 | |
| 5 | 2021 | 20 | |
| 6 | 2021 | 20 | |
| 7 | 2021 | 18 | |
| 8 | 2021 | 17 | |
| 9 | 2021 | 9 | |
| 10 | 2022 | 4 | |
| 11 | 2024 | 2 | |
| 12 | 2023 | 2 | |
| 13 | 2021 | 1 | |
| 14 | 2020 | 1 |
About Elena Croce
Elena Croce is a scholar working on Oncology, Immunology, Epidemiology, Molecular Biology and Ophthalmology, having authored 14 papers that have together received 243 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), CAR-T cell therapy research (3 papers), Cutaneous Melanoma Detection and Management (2 papers), Melanoma and MAPK Pathways (2 papers), Nonmelanoma Skin Cancer Studies (2 papers), Ocular Oncology and Treatments (2 papers) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Oncology (128 citations), Immunology (51 citations), Ophthalmology (20 citations), Dermatology (10 citations) and Epidemiology (27 citations). Elena Croce has collaborated with scholars based in Italy. Frequent co-authors include Francesco Spagnolo, Enrica T. Tanda, Andrea Boutros, Luca Arecco, Paola Queirolo, Matteo Lambertini, Marco Ferrari, P. Pronzato, Riccardo Marconcini and Giulia Massaro. Their work appears in journals such as Frontiers in Oncology, European Journal of Cancer, European Journal of Clinical Investigation, Journal of Geriatric Oncology and Critical Reviews in Oncology/Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.